1 February 2012 - 8:40am | posted by | 0 comments

Chime Communication commits to Succinct buy-out

Chime Communication commits to Succinct buy-outChime Communication commits to Succinct buy-out

Marketing services group Chime Communications has announced that it has agreed to take a 100% stake in Succinct Communications Ltd (SCL) – a specialist in medical communications for prescription medicines.

SCL’s clients include the likes of Bayer, GE, GSK, Roche and Senofi and it will continue to operate under its existing management team led by owner directors Sean McGrath and Lisa Dodgshon.
The acquisition constitutes an attempt by Chime to diversify its own healthcare arm, OPEN Health.

Lord Bell, Chairman of Chime Communications, commented: ”As a diversified communications group we see healthcare as an attractive sector in which we wish to compete strongly. The acquisition of SCL strengthens our recently established healthcare practice OPEN Health still further.”

David Rowley, Chief Executive of OPEN Health, said: ”High science and evidence based communications is the growth sector in healthcare communications, and OPEN Health intend to build a significant practice in this area. Sean and Lisa have built a fabulous business in Succinct Communications, and I have no doubt that in partnership with OPEN Health, the company will continue its impressive growth curve.”

Be the first to comment on this article: sign in or register.

Latest Projects from the Profile Hub

Malibu - creating the perfect brand moment to enhance engagement

17/12/2014
The challenge How do you change customers’ perception of...

Driving Sales From Social During Black Friday

16/12/2014
The craze of Black Friday crossed the pond and hit the UK...

BREACH: LETS JACK

16/12/2014
‘Jack’ – the infectious track by British producer Breach...

Launching the Seasonal Cities App

15/12/2014
In Q3 2014 Rooster was tasked with launching the new travel...

Helping a new fitness brand get into shape

12/12/2014
A new concept in gym fitness is being developed and we’re...